Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04551339 · ClinicalTrials.gov registry record · NA

Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19

A NA study of Healthy and Aging, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
2,700
Enrollment target
3
Study locations

NCT04551339 is a NA study of Healthy and Aging that has completed, run by Mayo Clinic. The registered enrollment target is 2,700 participants, above the 645-participant average among 1,090 other Healthy trials with a reported enrollment target (319% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04551339, a NA study of Healthy and Aging, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
2,700 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this research study is to look at high dose zinc versus multivitamin micronutrient supplementation to support immune health in the setting of the COVID-19 pandemic.

Interventions

  • DIETARY_SUPPLEMENT PreserVision AREDS formulation soft gels or tablets
  • DIETARY_SUPPLEMENT Multivitamin with 11mg of zinc

Study Locations (3)

Arizona

  • Mayo Clinic in Scottsdale - Scottsdale

Florida

  • Mayo Clinic in Jacksonville - Jacksonville

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 2,700 participants
Start Date 2020-09-28
Est. Completion 2021-05-28
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04551339

The ClinicalTrials.gov registry entry for NCT04551339 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,700 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 645-participant average among 1,090 other Healthy trials with a reported enrollment target (319% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which PreserVision AREDS formulation soft gels or tablets is the first listed.

NCT04551339 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT04551339 about?

NCT04551339 is a clinical study titled "Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19". The purpose of this research study is to look at high dose zinc versus multivitamin micronutrient supplementation to support immune health in the setting of the COVID-19 pandemic.

What is the current status of trial NCT04551339?

This trial is currently completed. It is a NA study. The enrollment target is 2,700 participants. The study started on 2020-09-28. Estimated completion is 2021-05-28.

What conditions does trial NCT04551339 study?

This clinical trial studies the following conditions: Healthy, Aging, Health Care Worker Patient Transmission.

What interventions are being tested in trial NCT04551339?

The interventions under investigation include: PreserVision AREDS formulation soft gels or tablets (DIETARY_SUPPLEMENT), Multivitamin with 11mg of zinc (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04551339?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04551339 being conducted?

This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.